G308A polymorphism of TNF-alpha gene is associated with insulin resistance and histological changes in non alcoholic fatty liver disease patients

Annals of Hepatology

Volumn 9, Issue 4, 2010, Pages 439-444

  Aller, Rocio ^a,b   de Luis, Daniel Antonio ^b   Izaola, Olatz ^b   Sagrado, Manuel González ^b   Conde, Rosa ^b   Gago, Tomas Alvarez ^a   Pacheco, David ^b   González, Jose Manuel ^a   Velasco, María Concepcion ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Insulin resistance; Liver biopsy; TNF alpha

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD ANALYSIS; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LIVER BIOPSY; LIVER FIBROSIS; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR NECROSIS FACTOR ALPHA GENE; FATTY LIVER; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY;

ADULT; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVERWEIGHT; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952343052     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31620-5     Document Type: Article

References (30)

1. Ludwig J, Viggiano TR, McGill DB, et al. Nonalcoholic stea-tohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proc 1980; 55: 434-438.
2. Kral JG, Schaffner F, Pierson RN, et al. Body fat topography as an independent predictor of fatty liver. Metabolism 1993; 42: 548-551.
3. Aller R, de Luis DA, Fernandez L, et al. Influence of insulin resistance and adipokines in the grade of steatosis of non-alcoholic fatty liver disease. Dig Dis Sci 2008; 53: 1088-1092.
4. Marceau P, Biron S, Hould FS, et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endo-crinol Metab 1999; 84: 1513-1517.
5. Hui JM, Hodge A, Farrell GC, et al. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 2004; 40: 46-54.
6. Qi C, Pekala PH. Tumor necrosis factor alpha induced insulin resistance in adipocytes. Proc Soc Exp Biol Med 2000; 223: 128-135.
7. Wilson AG, Simons JA, McDowell TL, et al. Effects of polymorphism of TNF alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199.
8. Fernandez RJM, Gutierrez C, Ricart W, et al. The TNF alpha gene NCO I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 1997; 46: 1468-1471.
9. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001; 21: 3-16.
10. Duart MJ, Arroyo CO, Moreno JL. Validation of a insulin model for the reactions in RIA. Clin Chem Lab Med 2002; 40: 1161-1167.
11. Mathews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-414.
12. Khan SS, Smith MS, Reda D, et al. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufactures. Cytometry B Clin Cytom 2004; 61: 35-39.
13. Bayley JP, de Rooij H, van den Elsen PJ, et al. Functional analysis of linker scan mutants spanning the -376, -308,-244, and -238 polymorphic sites of the TNF alpha promoter. Cytokine 2001; 14: 316-323.
14. Zhang B, Berger J, Hu E, et al. Negative regulation of pe-roxisome proliferators-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor alpha. Mol Endocrinol 1996: 10: 1457-1466.
15. Stephens JM, Pekala PH. Transcriptional representation of the glut 4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J Biol Chem 1991; 266: 21839-21845.
16. Marchesini G, Brizi M, Morselli-Labate A, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J of Medicine 1999; 107: 450-454.
17. Sanyal AJ, Campbell SC, et al. Nonalcoholic steatohepati-tis: association of insulin resistance and mitocohondrial abnormalities. Gastroenterology 2001; 120: 1183-1192.
18. Rashid M, Roberts EA. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 2000; 30: 48-53.
19. Chitturi S, Abeygunasekera S, Farrell G, et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 73: 373-378.
20. Venturi C, Zoppini G, Zamboni C, et al. Insulin sensivity and hepatic steatosis in obese subjects with normal glucose tolerance. Nutr Metab Cardiovsc Dis 2004: 14: 200-204.
21. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004: 114: 147-152.
22. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Lin Investig 2003; 112: 1785-1788.
23. Tomita K, Tamiya S, Ando S. TNF alpha signalling through activation Kupffer cells plays and essential role in liver fi-brosis of non-alcoholic steatohepatitis in mice. Gut 2006: 55: 415-424.
24. Li Z, Yang S, Lin H. Probiotics and antibodies to TNF inhibit inflammatory activity and improve NAFLD. Hepatology 2003; 37: 343-350.
25. Abiru S, Migita K, Maeda Y. Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis. Liver International 2006; 26: 39-45.
26. Musso G, Gambino M, Durazzo M. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 2005; 42: 1175-1183.
27. Valenti L, Fracanzani AL, Dongiovanni P. Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in non-alcoholic fatty liver disease. Gastroenterology 2002; 122: 274-280.
28. Tokushige K, Takakura M, Tsuchiya Matsushita M, et al. Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis. J Hepatol 2007; 1104-1110.
29. Pastor IJ, Laso FJ, Romero A, et al. 238 GA polymorphism of TNF alpha is associated with alcoholic liver cirrhosis in alcoholic Spanish men. Alcohol CLin Exp Res 2005; 29: 1928-1931.
30. Carulli L, Canedi I, Rondinella S, et al. Genetic polymorphisms in non-alcoholic fatty liver disease inter-leukin-6-174G/C polymorphism is associated with non alcoholic steatohepatitis. Dig Liver Dis 2009; 41: 823-828.